8-K filing — KALA BIO, Inc. (KALA)
Filed: 2026-09-10 AccNo: 0001829126-26-009999 Size: 454 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Kala Bio Announces Non-Binding LOI With Unnamed U.S. DNA Testing Platform To Resell Virotek Genetic Tests; Terms Not Finalized
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Kala Bio And Virotek Finalizes Definitive Exclusive Distribution And Reseller Agreement And Related Quality, Brand, And Data Protection Agreements
Kala Bio, Inc. (NASDAQ:KALA) ("Kala") and Virotek Inc. ("Virotek") today announced that they have finalized a definitive exclusive distribution and reseller agreement (the "Agreement") and
KALA BIO shares are trading lower. The company announced it has entered into a letter of intent with Virotek.